{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:44:33Z","timestamp":1791499473754,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFA0800601"],"award-info":[{"award-number":["2018YFA0800601"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82022006"],"award-info":[{"award-number":["82022006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["cstc2021jcyj-jqX0002"],"award-info":[{"award-number":["cstc2021jcyj-jqX0002"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["cstc2019jcyj-msxmX0152"],"award-info":[{"award-number":["cstc2019jcyj-msxmX0152"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Army Medical Center of PLA","award":["2019CXLCB008"],"award-info":[{"award-number":["2019CXLCB008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Altered adipokine secretion in dysfunctional adipose tissue facilitates the development of atherosclerotic diseases including lower extremity peripheral artery disease (PAD). Asprosin is a recently identified adipokine and displays potent regulatory role in metabolism, but the relationship between asprosin and lower extremity PAD remains uninvestigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      33 type 2 diabetes mellitus (T2DM) patients (DM), 51 T2DM patients with PAD (DM\u2009+\u2009PAD) and 30 healthy normal control (NC) volunteers were recruited and the blood samples were collected for detecting the circulatory asprosin level and metabolomic screening. RNA sequencing was performed using the aorta tissues from the type 2 diabetic\n                      <jats:italic>db\/db<\/jats:italic>\n                      mice and human umbilical vein endothelial cells (HUVECs) were treated with asprosin to determine its impact on the endothelial-to-mesenchymal transition (EndMT).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The circulating levels of asprosin in DM\u2009+\u2009PAD group were significantly higher than that of NC group and the DM group. Circulating asprosin level was remarkably negatively correlated with ankle-brachial index (ABI), even after adjusting for age, sex, body mass index (BMI) and other traditional risk factors of PAD. Logistic regression analysis revealed that asprosin is an independent risk factor for PAD and receiver-operator characteristic (ROC) curve determined a good sensitivity (74.5%) and specificity (74.6%) of asprosin to distinguish PAD. Data from metabolomics displayed a typical characteristics of de novo amino acid synthesis in collagen protein production by myofibroblasts in patients with PAD and activation of TGF-\u03b2 signaling pathway appeared in the aortic tissue of\n                      <jats:italic>db\/db<\/jats:italic>\n                      mice. Asprosin directly induces EndMT in HUVECs in a TGF-\u03b2-dependent manner as TGF-\u03b2 signaling pathway inhibitor SB431542 erased the promotional effect of asprosin on EndMT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated circulatory asprosin level is an independent risk factor of lower extremity PAD and might serve as a diagnostic marker. Mechanistically, asprosin directly induces EndMT that participates in vascular injury via activation of TGF-\u03b2 signaling pathway.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      This trial was registered at clinicaltrials.gov as NCT05068895\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-022-01457-0","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T10:02:34Z","timestamp":1644919354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease"],"prefix":"10.1186","volume":"21","clinical-trial-number":[{"clinical-trial-number":"nct05068895","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mei","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingbing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhencheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"issue":"12","key":"1457_CR1","first-page":"e726","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College Of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135(12):e726\u201379.","journal-title":"Circulation"},{"issue":"5","key":"1457_CR2","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1016\/S2214-109X(20)30117-0","volume":"8","author":"P Song","year":"2020","unstructured":"Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y, Fowkes FGR, Fowkes FJI, Rudan I. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8(5):e721\u20139.","journal-title":"Lancet Glob Health"},{"issue":"9","key":"1457_CR3","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","volume":"144","author":"MH Criqui","year":"2021","unstructured":"Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F, American Heart Association Council on E, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):e171\u201391.","journal-title":"Circulation."},{"issue":"18","key":"1457_CR4","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jacc.2010.04.060","volume":"56","author":"MH Criqui","year":"2010","unstructured":"Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, Ix JH, Burke GL, Liu K, Shea S. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2010;56(18):1506\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1457_CR5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","volume":"116","author":"MH Criqui","year":"2015","unstructured":"Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509\u201326.","journal-title":"Circ Res"},{"issue":"10","key":"1457_CR6","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1172\/JCI129187","volume":"129","author":"CR Kahn","year":"2019","unstructured":"Kahn CR, Wang G, Lee KY. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J Clin Invest. 2019;129(10):3990\u20134000.","journal-title":"J Clin Invest"},{"issue":"9","key":"1457_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41574-019-0230-6","volume":"15","author":"L Scheja","year":"2019","unstructured":"Scheja L, Heeren J. The endocrine function of adipose tissues in health and cardiometabolic disease. Nat Rev Endocrinol. 2019;15(9):507\u201324.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"1457_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.numecd.2016.12.005","volume":"27","author":"M Ruscica","year":"2017","unstructured":"Ruscica M, Baragetti A, Catapano AL, Norata GD. Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: gaps and open questions. Nutr Metab Cardiovasc Dis. 2017;27(5):379\u201395.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"1457_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B, et al. Asprosin, a fasting-induced glucogenic protein hormone. Cell. 2016;165(3):566\u201379.","journal-title":"Cell"},{"issue":"1","key":"1457_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jcp.29835","volume":"236","author":"R Wang","year":"2021","unstructured":"Wang R, Hu W. Asprosin promotes beta-cell apoptosis by inhibiting the autophagy of beta-cell via AMPK-mTOR pathway. J Cell Physiol. 2021;236(1):215\u201321.","journal-title":"J Cell Physiol"},{"key":"1457_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","volume":"489","author":"L Zhang","year":"2019","unstructured":"Zhang L, Chen C, Zhou N, Fu Y, Cheng X. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin Chim Acta. 2019;489:183\u20138.","journal-title":"Clin Chim Acta"},{"key":"1457_CR12","doi-asserted-by":"publisher","first-page":"7375294","DOI":"10.1155\/2018\/7375294","volume":"2018","author":"X Li","year":"2018","unstructured":"Li X, Liao M, Shen R, Zhang L, Hu H, Wu J, Wang X, Qu H, Guo S, Long M, et al. Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators Inflamm. 2018;2018:7375294.","journal-title":"Mediators Inflamm"},{"issue":"17","key":"1457_CR13","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1161\/01.CIR.0000095273.92468.D9","volume":"108","author":"G Brevetti","year":"2003","unstructured":"Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108(17):2093\u20138.","journal-title":"Circulation"},{"issue":"4","key":"1457_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","volume":"63","author":"G Basta","year":"2004","unstructured":"Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63(4):582\u201392.","journal-title":"Cardiovasc Res"},{"issue":"8","key":"1457_CR15","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1161\/ATVBAHA.116.306717","volume":"36","author":"CY Ho","year":"2016","unstructured":"Ho CY, Shanahan CM. Medial arterial calcification: an overlooked player in peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2016;36(8):1475\u201382.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1457_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/path.5193","volume":"247","author":"G Sanchez-Duffhues","year":"2019","unstructured":"Sanchez-Duffhues G, Vinuesa GA, van de Pol V, Geerts ME, de Vries MR, Janson SG, van Dam H, Lindeman JH, Goumans MJ, Dijke TP. Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2. J Pathol. 2019;247(3):333\u201346.","journal-title":"J Pathol."},{"issue":"9","key":"1457_CR17","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/ATVBAHA.121.313788","volume":"41","author":"Z Alvandi","year":"2021","unstructured":"Alvandi Z, Bischoff J. Endothelial-mesenchymal transition in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021;41(9):2357\u201369.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1457_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fcell.2020.00260","volume":"8","author":"J Ma","year":"2020","unstructured":"Ma J, Sanchez-Duffhues G, Goumans MJ, Ten Dijke P. TGF-beta-induced endothelial to mesenchymal transition in disease and tissue engineering. Front Cell Dev Biol. 2020;8:260.","journal-title":"Front Cell Dev Biol"},{"key":"1457_CR19","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.2147\/DMSO.S283413","volume":"13","author":"X Deng","year":"2020","unstructured":"Deng X, Zhao L, Guo C, Yang L, Wang D, Li Y, Xia H, Wang C, Cai Z, Li L, et al. Higher serum asprosin level is associated with urinary albumin excretion and renal function in type 2 diabetes. Diabetes Metab Syndr Obes. 2020;13:4341\u201351.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1457_CR20","doi-asserted-by":"crossref","unstructured":"American Diabetes A: 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020; 43(Suppl 1):S14-S31.","DOI":"10.2337\/dc20-S002"},{"issue":"5","key":"1457_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7547\/1000406","volume":"100","author":"CA Andersen","year":"2010","unstructured":"Andersen CA. Noninvasive assessment of lower-extremity hemodynamics in individuals with diabetes mellitus. J Am Podiatr Med Assoc. 2010;100(5):406\u201311.","journal-title":"J Am Podiatr Med Assoc"},{"key":"1457_CR22","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s00726-021-02996-8","volume":"53","author":"RB Hamanaka","year":"2021","unstructured":"Hamanaka RB, Mutlu GM. The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer. Amino Acids. 2021;53:1851.","journal-title":"Amino Acids."},{"issue":"2","key":"1457_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","volume":"16","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK, Antoniades C. The role of adipose tissue in cardiovascular health and disease. Nat Rev Cardiol. 2019;16(2):83\u201399.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"1457_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/ATVBAHA.112.301089","volume":"33","author":"MM Joosten","year":"2013","unstructured":"Joosten MM, Joshipura KJ, Pai JK, Bertoia ML, Rimm EB, Mittleman MA, Mukamal KJ. Total adiponectin and risk of symptomatic lower extremity peripheral artery disease in men. Arterioscler Thromb Vasc Biol. 2013;33(5):1092\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1457_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12933-020-01151-z","volume":"19","author":"F Biscetti","year":"2020","unstructured":"Biscetti F, Nardella E, Rando MM, Cecchini AL, Angelini F, Cina A, Iezzi R, Filipponi M, Santoliquido A, Pitocco D, et al. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study. Cardiovasc Diabetol. 2020;19(1):170.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1457_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12933-021-01411-6","volume":"20","author":"NPE Kadoglou","year":"2021","unstructured":"Kadoglou NPE, Korakas E, Karkos C, Maratou E, Kanonidis I, Plotas P, Papanas N, Moutsatsou P, Ikonomidis I, Lambadiari V. The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization. Cardiovasc Diabetol. 2021;20(1):221.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"1457_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/diagnostics10090723","volume":"10","author":"A Ceasovschih","year":"2020","unstructured":"Ceasovschih A, Sorodoc V, Onofrei Aursulesei V, Tesloianu D, Tuchilus C, Anisie E, Petris A, Statescu C, Jaba E, Stoica A, et al. Biomarker utility for peripheral artery disease diagnosis in real clinical practice: a prospective study. Diagnostics (Basel). 2020;10(9):723.","journal-title":"Diagnostics (Basel)"},{"key":"1457_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijcard.2021.09.055","volume":"344","author":"PK Garg","year":"2021","unstructured":"Garg PK, Lima J, deFilippi CR, Daniels LB, Seliger SL, de Lemos JA, Maisel AS, Criqui MH, Bahrami H. Associations of cardiac injury biomarkers with risk of peripheral artery disease: the multi-ethnic study of atherosclerosis. Int J Cardiol. 2021;344:199\u2013204.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1457_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12933-021-01319-1","volume":"20","author":"JW Gao","year":"2021","unstructured":"Gao JW, Hao QY, Gao M, Zhang K, Li XZ, Wang JF, Vuitton DA, Zhang SL, Liu PM. Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study. Cardiovasc Diabetol. 2021;20(1):126.","journal-title":"Cardiovasc Diabetol"},{"key":"1457_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cytogfr.2021.05.002","volume":"60","author":"K Shabir","year":"2021","unstructured":"Shabir K, Brown JE, Afzal I, Gharanei S, Weickert MO, Barber TM, Kyrou I, Randeva HS. Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: comprehensive review of preclinical and clinical evidence. Cytokine Growth Factor Rev. 2021;60:120\u201332.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1457_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13098-020-00564-w","volume":"12","author":"S Naiemian","year":"2020","unstructured":"Naiemian S, Naeemipour M, Zarei M, Lari Najafi M, Gohari A, Behroozikhah MR, Heydari H, Miri M. Serum concentration of asprosin in new-onset type 2 diabetes. Diabetol Metab Syndr. 2020;12:65.","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"1457_CR32","doi-asserted-by":"publisher","first-page":"20888","DOI":"10.1002\/jcp.28694","volume":"234","author":"TW Jung","year":"2019","unstructured":"Jung TW, Kim HC, Kim HU, Park T, Park J, Kim U, Kim MK, Jeong JH. Asprosin attenuates insulin signaling pathway through PKCdelta-activated ER stress and inflammation in skeletal muscle. J Cell Physiol. 2019;234(11):20888\u201399.","journal-title":"J Cell Physiol"},{"issue":"1","key":"1457_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5603\/EP.a2020.0059","volume":"72","author":"N Gozel","year":"2021","unstructured":"Gozel N, Kilinc F. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin. Endokrynol Pol. 2021;72(1):37\u201343.","journal-title":"Endokrynol Pol"},{"issue":"1","key":"1457_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13098-021-00652-5","volume":"13","author":"A Jiang","year":"2021","unstructured":"Jiang A, Feng Z, Yuan L, Zhang Y, Li Q, She Y. Effect of sodium-glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus. Diabetol Metab Syndr. 2021;13(1):34.","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"1457_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73(3):924\u201367.","journal-title":"Pharmacol Rev"},{"issue":"8","key":"1457_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41569-018-0023-y","volume":"15","author":"Y Li","year":"2018","unstructured":"Li Y, Lui KO, Zhou B. Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases. Nat Rev Cardiol. 2018;15(8):445\u201356.","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"1457_CR37","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1172\/JCI82719","volume":"125","author":"PY Chen","year":"2015","unstructured":"Chen PY, Qin L, Baeyens N, Li G, Afolabi T, Budatha M, Tellides G, Schwartz MA, Simons M. Endothelial-to-mesenchymal transition drives atherosclerosis progression. J Clin Invest. 2015;125(12):4514\u201328.","journal-title":"J Clin Invest"},{"key":"1457_CR38","doi-asserted-by":"publisher","first-page":"11853","DOI":"10.1038\/ncomms11853","volume":"7","author":"SM Evrard","year":"2016","unstructured":"Evrard SM, Lecce L, Michelis KC, Nomura-Kitabayashi A, Pandey G, Purushothaman KR, d\u2019Escamard V, Li JR, Hadri L, Fujitani K, et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun. 2016;7:11853.","journal-title":"Nat Commun"},{"issue":"9","key":"1457_CR39","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s42255-019-0102-3","volume":"1","author":"PY Chen","year":"2019","unstructured":"Chen PY, Qin L, Li G, Wang Z, Dahlman JE, Malagon-Lopez J, Gujja S, Cilfone NA, Kauffman KJ, Sun L, et al. Endothelial TGF-beta signalling drives vascular inflammation and atherosclerosis. Nat Metab. 2019;1(9):912\u201326.","journal-title":"Nat Metab"},{"issue":"10","key":"1457_CR40","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/01.STR.0000140739.45472.9c","volume":"35","author":"F Cipollone","year":"2004","unstructured":"Cipollone F, Fazia M, Mincione G, Iezzi A, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, Di Nisio M, Cuccurullo F, et al. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke. 2004;35(10):2253\u20137.","journal-title":"Stroke"},{"issue":"2","key":"1457_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/JOE-20-0503","volume":"249","author":"Y Miao","year":"2021","unstructured":"Miao Y, Qin H, Zhong Y, Huang K, Rao C. Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue. J Endocrinol. 2021;249(2):83\u201393.","journal-title":"J Endocrinol"},{"key":"1457_CR42","doi-asserted-by":"publisher","first-page":"726783","DOI":"10.3389\/fphys.2021.726783","volume":"12","author":"M Kantorowicz","year":"2021","unstructured":"Kantorowicz M, Szymura J, Szygula Z, Kusmierczyk J, Maciejczyk M, Wiecek M. Nordic walking at maximal fat oxidation intensity decreases circulating asprosin and visceral obesity in women with metabolic disorders. Front Physiol. 2021;12:726783.","journal-title":"Front Physiol."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01457-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01457-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01457-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T09:03:30Z","timestamp":1666515810000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01457-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1457"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01457-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Army Medical Center of PLA (Number 93\/2021) and adhered to the principles of the Declaration of Helsinki. All participants agreed to participate in the study and gave informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent to publish was obtained from all participants in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}